PharmiWeb3h
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
Endocrinology Advisor16h
January 2025 Recap: Drug Pipeline Updates
The table below is a review of notable updates that occurred in January 2025 for investigational products in development.
Drug Store News5d
Novo Nordisk to cap insulin prices in Minnesota settlement
The settlement filed in Newark, N.J. federal court comes after similar settlements with Eli Lilly and Sanofi last year. It ...
FierceBiotech6d
Eli Lilly's next R&D focus: Testing incretin meds in neuro, immunology fields
Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...
Top Driver In The Novolog Or Novomix Or Novorapid 2025: Rising Diabetes Prevalence Drives Growth In The Market
The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
Top Growth Driver In The Novolog Mix 70/30 Market 2025: Rising Diabetes Prevalence Fuels Industry Growth
The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!